KyriakosPeterPapadopoulosMD

Clinical Trials

• Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 2001 Apr 01

  Terminated

  Phase 1

• Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma Start of enrollment: 2001 Oct 01

  Unknown status

  Phase 1

• Study of NMS-1116354 in Solid Tumors Start of enrollment: 2009 Apr 01

  Terminated

  Phase 1

• Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors Start of enrollment: 2010 Oct 01

  Completed

  Phase 1, Phase 2

• A Study of DS-2248 in Participants With Advanced Solid Tumors Start of enrollment: 2011 Mar 29

  Terminated

  Phase 1

• Study of PM060184 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Jan 01

  Completed

  Phase 1

• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors Start of enrollment: 2013 Nov 15

  Active, not recruiting

  Phase 1

• CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) Start of enrollment: 2016 Feb 01

  Recruiting

  Phase 1

• Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression Start of enrollment: 2017 May 18

  Terminated

  Phase 1

• A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors Start of enrollment: 2017 Sep 12

  Terminated

  Phase 1

• Join now to see all